• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Palamon takes over Carlyle's IDH stake

  • Harriet Matthews
  • Harriet Matthews
  • 28 May 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Palamon Partners has acquired the stake held by Carlyle in dental treatment and supplies business IDH Group, investing in the business alongside management to become the sole sponsor backing the firm.

The deal is expected to close in Q3 2021.

Palamon has also acquired further stakes from several minority shareholders, the GP said in a statement.

IDH

  • DEAL:

    Buyout; exit

  • LOCATION:

    Manchester

  • SECTOR:

    Healthcare providers

  • FOUNDED:

    1996

  • TURNOVER:

    £440m (2020)

  • EBITDA:

    £45.8m (2020)

  • VENDOR:

    Carlyle Group

A new management team was introduced in 2017, according to a statement. CEO Tom Riall and CFO Nilesh Pandya will continue to lead the company following its change in ownership, according to a statement.

Unquote sister publication Mergermarket first reported in August 2020 that IDH was up for sale, with a valuation multiple expected to be in the mid-teens. Mergermarket later reported that IDH was to be marketed based on EBITDA of £62-72m.

BC Partners, Advent International and TDR were cited in a report from Mergermarket in October 2020 as interested bidders.

IDH confirmed in February 2021 that it had entered into discussions with a preferred bidder for a sale of all shares or a majority stake in the company, with Sky News subsequently reporting that Bridgepoint had been chosen as the preferred bidder.

Sky News reported earlier in May 2021 that Palamon was expected to make a £700m offer for IDH, matching the offer already on the table from Bridgepoint.

IDH confirmed in a statement that the offer from Palamon supersedes the announcement made by the company on 12 April that it had entered into a binding agreement with an unnamed purchaser and Turnstone Equityco 1.

Previous funding
Bank of America Merrill Lynch Capital Partners (BAML CP) acquired IDH in 2008 from LGV Capital in a deal that valued the company at around £300m.

Carlyle took a 75% stake in IDH from BAML CP in 2011 via Carlyle Europe Partners III. The vehicle held a final close in September 2007 on €5.35bn and was fully deployed as of September 2019, according to Unquote Data.

Carlyle's acquisition of IDH saw the company merge with Associated Dental Practices (ADP), which Palamon Capital Partners had acquired in 2009 via Palamon European Equity II. The fund held a final close in July 2006 on €670m. Palamon rolled over its stake in ADP to take a minority stake in the combined entity. The deal valued IDH at around £450m and the combined group at approximately £600m, equating to an entry multiple of around 10x the combined group's £55-60m EBITDA. ING, Bank of Ireland, Lloyds and Societe Generale provided debt to back the deal.

Company
IDH operates a network of around 600 dental practices via its MyDentist brand and also supplies dental and beauty products to around 12,000 dental practices and 6,000 beauty clinics via its DD brand. Under the MyOptions brand, IDH also offers private dental treatment options. The company is headquartered in Manchester and was founded in 1996.

According to its latest financial report, IDH posted adjusted pro forma EBITDA of £45.8m in 2020 and revenues of £446m.

People
Palamon Partners – Fabio Massimo Giuseppetti (partner).
IDH Group – Tom Riall (CEO); Nilesh Pandya (CFO).

Advisers
Equity – Slaughter and May (legal); Goodwin (legal); PwC (tax); DC Advisory (M&A, debt advisory).
Company – Kirkland & Ellis (legal); JP Morgan Cazenove (M&A); Gleacher Shacklock (M&A).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Exits
  • Healthcare
  • United Kingdom
  • Carlyle Group
  • Palamon Capital Partners

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013